Yeong Mun Kim

Title: Yeong Mun Kim: Innovator in Immunocytokine Technology

Introduction

Yeong Mun Kim is a notable inventor based in Bucheon-si, South Korea. He has made significant contributions to the field of biotechnology, particularly in the development of immunocytokines. His work focuses on enhancing the efficacy of therapeutic agents for serious medical conditions.

Latest Patents

Yeong Mun Kim holds a patent for a "Human interferon-beta variant conjugated immunocytokine and method for preparing same." This invention relates to an immunocytokine where a human interferon-beta variant is conjugated to an antibody or a fragment thereof. The human interferon-beta variant demonstrates superior activity compared to natural interferon-beta, and the productivity of the immunocytokine is exceptional. This innovative immunocytokine can be effectively utilized as a targeted therapeutic agent for multiple sclerosis or cancer, as it combines the functions of interferon-beta with the characteristics of an antibody that binds to specific antigens.

Career Highlights

Yeong Mun Kim is currently associated with Genopharm Inc., where he continues to advance his research and development efforts. His work has positioned him as a key figure in the biotechnology sector, contributing to the development of novel therapeutic solutions.

Collaborations

Yeong Mun Kim collaborates with Young Kee Shin, enhancing the research capabilities and innovation potential within their projects.

Conclusion

Yeong Mun Kim's contributions to immunocytokine technology highlight his role as an influential inventor in the biotechnology field. His innovative approaches have the potential to significantly impact the treatment of serious diseases.